期刊文献+

虫草肾茶胶囊对人肾小球系膜细胞TGF-β_1 mRNA及PAI-1mRNA表达的影响 被引量:2

Research of Capsule of Chong-cao Shen-cha on the Expressions of HMC TGF-β_1 mRNA and PAI-1mRNA
下载PDF
导出
摘要 目的:研究虫草肾茶胶囊对培养在高糖条件下人肾小球系膜细胞(HMC)转化生长因子-β1mRNA(TGF-β1mRNA)和纤维蛋白溶解酶原激活物抑制剂-1mRNA(PAI-1mRNA)表达的影响,探讨其在糖尿病肾病(DN)防治中的意义。方法:制备虫草肾茶胶囊及福辛普利药物血清,用实时定量PCR方法测定各组HMCTGF-β1以及PAI-1mRNA表达,并以福辛普利为对照。结果:虫草肾茶胶囊高、中剂量组及福辛普利组TGF-β1mRNA和PAI-1mRNA表达均低于高糖组,且以虫草肾茶胶囊高剂量组表达最低(P<0.05)。结论:高糖可促进HMCTGF-β1mRNA和PAI-1mRNA表达,虫草肾茶胶囊可下调高糖刺激下HMCTGF-β1mRNA及PAI-1mRNA的表达,从而预防肾小球硬化的发生、发展,进而延缓DN的进展。 Objective:To study the influence of Capsule of Chong-cao Shen-cha on the expressions of TGF-β1mRNA and PAI-1mRNA in anthropo-mesangial cell(HMC) under the condition of high glucose,and investigate the significance on diabetic nephropathy.Method: At first Capsule of Chong-cao Shen-cha and fosinopril serum were made.Then the expressions of HMC TGF-β1 mRNA and PAI-1mRNA were detected in each group with the method of real-time-quantitation-PCR,and fosinopril was as the control.Result: The expressions of TGF-β1mRNA and PAI-1mRNA were lower in high and medium dose groups of Capsule of Chong-cao Shen-cha and fosinopril group than in high glucose group.And the expressions of them in high dose group of Capsule of Chong-cao Shencha were the lowest(P0.05).Conclusion: High glucose can promote the expressions of HMC TGF-β1mRNA and PAI-1mRNA,and Capsule of Chong-cao Shen-cha can do down regulation on the expressions of them stimulated by high glucose.So Capsule of Chong-cao Shen-cha can prevent beforehand from the occurrence and advancement of glomerular sclerosis,and then defer the progression of DN.
出处 《山西中医》 2011年第5期44-46,共3页 Shanxi Journal of Traditional Chinese Medicine
基金 黑龙江省教育厅科学技术研究项目(编号:11511357)
关键词 虫草肾茶胶囊 人肾小球系膜细胞 转化生长因子-Β1 纤维蛋白溶解酶原激活物抑制剂-1 实验研究 Capsule of Chong-cao Shen-cha anthropo-mesangial cell TGF-β1 fibrinoclase proenzyme activator inhibiter-1(PAI-1mRNA) experimental study
  • 相关文献

参考文献4

二级参考文献4

共引文献4

同被引文献31

  • 1郑美玲,樊均明.氧化应激对糖尿病肾病时细胞、细胞外基质及血管通透性的影响机制[J].中国组织工程研究与临床康复,2007,11(25):4988-4991. 被引量:24
  • 2Liu Y. Renal fibrosis:new insights into the pathogenesis and thera- peutics [ J ]. Kidney Int,2006,69:213 - 217.
  • 3Migliorini A, Ebid R, Scherbaum C R, et al. The danger control concept in kidney disease : mesangial cells [ J ]. Journal of Nephrology, 2013,26 (3) :437 -449.
  • 4Wada J, Makino H. Inflammation and the pathogenesis of diabetic ne- phropathy [ J ]. Clinical Seience,2013,124 ( 3 ) : 139 - 152.
  • 5Sanz AB, Sanchez - Nino MD, Ramos AM, et al. NF - kappaB in re- nal inflammation[ J]. Journal of the American Society of Nephrology: JASN,2010,21 (8) :1254.
  • 6Marrero M B, Banes - Berceli A K, Stem D M, et al. Role of the JAK/STAT signaling pathway in diabetic nephropathy [ J ]. American Journal of Physiology - Renal Physiology, 2006, 290 ( 4 ) : F762 - F768.
  • 7Han J, Jiang Y, Li Z, et al. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation [ J ]. Nature, 1997, 386(6622) :296 -299.
  • 8Suzuki D, Miyata T, Nangaku M, et al. Expression of megsin mR- NA, a novel mesangium - predominant gene, in the renal tissues of various glomerular diseases [ J ]. Journal of the American Society of Nephrology, 1999,10 ( 12 ) : 2606 - 2613.
  • 9Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis[ J]. Journal of the American Society of Nephrology:JASN,2010,21 ( 11 ) : 1819 - 1834.
  • 10Mauer S M, Steffes M W, Ellis E N, et al. Structural -functional re- lationships in diabetic nephropathy [ C ]//Journal of Clinical Investiga- tion, 1984:225 - 225.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部